布地奈德雾化吸入治疗小儿支原体肺炎的效果观察及临床评估
|
摘要
目的目的观察与评估布地奈德雾化吸入治疗小儿支原体肺炎的效果。方法选取本院收治的小儿支原体肺炎患儿100例为对象进行研究,根据不同治疗方法将其分为对照组和观察组,各50例。采取常规方法治疗对照组,在此基础上采用布地奈德雾化吸入治疗观察组。比较两组治疗前后肺功能指标变化、治疗效果以及各症状改善时间等。结果两组治疗前FVC、FEV1等指标比较差异不显著,且P>0.05;而治疗后观察组FVC、FEV1等指标与对照组相比差异显著,且P<0.05。观察组治疗有效率为98.0%(49/50)与对照组80.0%(40/50)相比显著较高,且P<0.05。观察组肺部炎症吸收、咳嗽获得控制、体温恢复等时间与对照组相比均显著较短,且P<0.05。结论针对小儿支原体肺炎患儿采取布地奈德雾化吸入治疗的效果非常显著,既能显著改善其肺功能,又能促使其各种症状快速改善,因此值得临床应用推广。
Objective To observe and evaluate the effect of budesonide inhalation in the treatment of children with mycoplasmal pneumonia. Methods A total of 100 children with mycoplasmal pneumonia in our hospital were enrolled in the study. According to different treatment methods, they were divided into control group and observation group, 50 cases in each group. The control group was treated by a conventional method, and the observation group was treated with budesonide inhalation. The changes of lung function indexes, treatment effects and time of improvement of each symptom were compared before and after treatment. Results There were no significant differences in FVC and FEV1 between the two groups before treatment, P>0.05. After treatment, the indexes of FVC and FEV1 in the observation group were significantly different from those in the control group, P<0.05. The therapeutic effective rate of the observation group was 98.0%(49/50), which was significantly higher than that of the control group(80.0%(40/50), P < 0.05. The time of inflammation absorption, cough control and body temperature recovery in the observation group were significantly shorter than those in the control group, and P<0.05. Conclusion The effect of budesonide inhalation therapy for children with mycoplasmal pneumonia in children is very significant. It can not only improve their lung function, but also promote their rapid improvement of various symptoms.Therefore, it is worthy of clinical application.
Objective To observe and evaluate the effect of budesonide inhalation in the treatment of children with mycoplasmal pneumonia. Methods A total of 100 children with mycoplasmal pneumonia in our hospital were enrolled in the study. According to different treatment methods, they were divided into control group and observation group, 50 cases in each group. The control group was treated by a conventional method, and the observation group was treated with budesonide inhalation. The changes of lung function indexes, treatment effects and time of improvement of each symptom were compared before and after treatment. Results There were no significant differences in FVC and FEV1 between the two groups before treatment, P>0.05. After treatment, the indexes of FVC and FEV1 in the observation group were significantly different from those in the control group, P<0.05. The therapeutic effective rate of the observation group was 98.0%(49/50), which was significantly higher than that of the control group(80.0%(40/50), P < 0.05. The time of inflammation absorption, cough control and body temperature recovery in the observation group were significantly shorter than those in the control group, and P<0.05. Conclusion The effect of budesonide inhalation therapy for children with mycoplasmal pneumonia in children is very significant. It can not only improve their lung function, but also promote their rapid improvement of various symptoms.Therefore, it is worthy of clinical application.
引文
[1]顾安信.阿奇霉素联合布地奈德雾化吸入治疗小儿支原体肺炎疗效观察[J].世界最新医学信息文摘,2016,16(64):110-111.
[2]黄晓英,张锦琪,孙晓玄,耿琼花.布地奈德雾化吸入联合阿奇霉素序贯疗法治疗小儿支原体肺炎的效果观察[J].实用临床医药杂志,2017,21(23):90-91.
[3]周宏霞.儿童重症肺炎支原体肺炎的临床治疗方式与疗效[J].世界最新医学信息文摘,2015,15(70):68.
[4]郑静,宋闻.阿奇霉素联合特布他林和布地奈德治疗小儿支原体肺炎的临床研究[J].中国妇幼保健,2016,31(13):2655-2657.
[5]肖东霞,孙继娜,张子才.布地奈德雾化吸入对肺炎支原体肺炎患儿临床症状、体液免疫功能和肺功能的影响[J].中国当代医药,2017(34):132-134,138.
[6]过莉芳.小儿支原体肺炎采用布地奈德雾化吸入法治疗的疗效探究[J].临床医学研究与实践,2018(2):50-51.
[7]徐丽曼.布地奈德雾化吸入治疗小儿支原体肺炎的疗效分析[J].中国实用医药,2018(4):89-90.
[8]刘云琴,张燕,张智玲.布地奈德混悬剂雾化吸入佐治小儿支原体肺炎临床观察[J].新疆医学,2017,47(11):1311-1312.
[9]马冬均,卢俊.布地奈德混悬液治疗小儿支原体肺炎的临床疗效评价[J].新疆医学,2013,43(10):49-51.
[2]黄晓英,张锦琪,孙晓玄,耿琼花.布地奈德雾化吸入联合阿奇霉素序贯疗法治疗小儿支原体肺炎的效果观察[J].实用临床医药杂志,2017,21(23):90-91.
[3]周宏霞.儿童重症肺炎支原体肺炎的临床治疗方式与疗效[J].世界最新医学信息文摘,2015,15(70):68.
[4]郑静,宋闻.阿奇霉素联合特布他林和布地奈德治疗小儿支原体肺炎的临床研究[J].中国妇幼保健,2016,31(13):2655-2657.
[5]肖东霞,孙继娜,张子才.布地奈德雾化吸入对肺炎支原体肺炎患儿临床症状、体液免疫功能和肺功能的影响[J].中国当代医药,2017(34):132-134,138.
[6]过莉芳.小儿支原体肺炎采用布地奈德雾化吸入法治疗的疗效探究[J].临床医学研究与实践,2018(2):50-51.
[7]徐丽曼.布地奈德雾化吸入治疗小儿支原体肺炎的疗效分析[J].中国实用医药,2018(4):89-90.
[8]刘云琴,张燕,张智玲.布地奈德混悬剂雾化吸入佐治小儿支原体肺炎临床观察[J].新疆医学,2017,47(11):1311-1312.
[9]马冬均,卢俊.布地奈德混悬液治疗小儿支原体肺炎的临床疗效评价[J].新疆医学,2013,43(10):49-51.